A Detour into Melanoma
Postdoctoral fellow Binita Chakraborty, PhD, was intrigued: in published analyses of large numbers of patients with melanoma (skin cancer) treated with an immunotherapy that is becoming standa
Estrogen receptors in mom's placenta critical during viral infection
Researchers at Duke and Mt. Sinai have identified a molecular mechanism that prevents a viral infection during a mother’s pregnancy from harming her unborn baby.
Q&A with Patrice Harris, MD: psychiatrist, advocate & leader
Patrice Harris, MD, MA, FAPA, a psychiatrist who served as the first African American woman president of the American Medical Association in 2019-2020, was inspired as a child to pursue medicine.
The Physics Behind Tumor Growth
New theory uses physics to predict the growth stages of cancerous tumors
An interview with Geeta Swamy on the safety of COVID vaccines
Duke University School of Medicine Dean Mary E.
2021 LEADER cohort announced
The School of Medicine Office for Faculty is pleased to announce the 2021 LEADER participants.
DCI researchers address health disparities in stomach and lung cancer
As the COVID-19 pandemic shines a light on health disparities, efforts to find new ways to reduce them get a boost.
At Duke, the future of pathology lies in AI
Duke Engineering and the Duke School of Medicine have joined forces to create a new Division of Artificial Intelligence and Computational Pathology.
School of Medicine Students Volunteer in Duke’s COVID-19 Vaccine Clinic
Duke medical and health professions students are playing a prominent role in the distribution of COVID-19 vaccines to the Duke Health community.
Recurrent GBM brain tumors with few mutations respond best to immunotherapy
The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival.